Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

GlaxoSmithKline Pakistan Ltd (GLAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
97.50 +0.15    +0.15%
06:27:40 - Closed. Currency in PKR ( Disclaimer )
Type:  Equity
Market:  Pakistan
ISIN:  PK0001301016 
S/N:  GLAXO
  • Volume: 260,000
  • Bid/Ask: 97.50 / 97.99
  • Day's Range: 96.50 - 100.75
GlaxoSmithKline Pakistan 97.50 +0.15 +0.15%

GLAX Balance Sheet

 
Featured here, the Balance Sheet for GlaxoSmithKline Pakistan Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 25340.64 26806.62 24018.1 25329.95
Cash and Short Term Investments 3610.76 3824.1 1562.86 2314.72
Cash - - - -
Cash & Equivalents 3610.76 3824.1 1562.86 2314.72
Short Term Investments - - - -
Total Receivables, Net 8586.86 9320.54 9268.21 10834.55
Accounts Receivables - Trade, Net 1028.47 1032.2 1182.99 1905.69
Total Inventory 11793.96 13336.55 12952.75 11889.62
Prepaid Expenses 190.74 - - -
Other Current Assets, Total 1158.32 325.43 234.27 291.06
Total Assets 38130.9 39097.57 36162.55 37437.66
Property/Plant/Equipment, Total - Net 11700.56 11217.22 11073.43 11066.66
Property/Plant/Equipment, Total - Gross 18933.78 - - -
Accumulated Depreciation, Total -7233.22 - - -
Goodwill, Net 955.74 - - 955.74
Intangibles, Net - 955.74 955.74 -
Long Term Investments - - - -
Note Receivable - Long Term 7505.82 6871.25 6518.59 7342.67
Other Long Term Assets, Total 50.15 33.23 33.23 27.52
Other Assets, Total 4501.8 5843.29 5567.49 2990.1
Total Current Liabilities 14564.72 16947.58 13769.27 14377.1
Accounts Payable 1615.98 5882.15 4295.38 4902.89
Payable/Accrued - - - -
Accrued Expenses 5403.87 5477.35 3971.34 3294.17
Notes Payable/Short Term Debt 572.93 - - -
Current Port. of LT Debt/Capital Leases 35.94 11.94 12.76 18.22
Other Current liabilities, Total 6936 5576.13 5489.8 6161.82
Total Liabilities 16455.06 18436.09 15431.28 15953.99
Total Long Term Debt 116.04 13.76 19.22 20.07
Long Term Debt - - - -
Capital Lease Obligations 116.04 13.76 19.22 20.07
Deferred Income Tax 1180.6 797.12 997.1 945.23
Minority Interest - - - -
Other Liabilities, Total 20.78 677.62 645.69 611.58
Total Equity 21675.84 20661.49 20731.28 21483.67
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 3184.67 3184.67 3184.67 3184.67
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 17364.25 16349.89 16419.68 17172.07
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 1126.92 1126.92 1126.92 1126.92
Total Liabilities & Shareholders' Equity 38130.9 39097.57 36162.55 37437.66
Total Common Shares Outstanding 318.47 317.23 318.47 318.47
Total Preferred Shares Outstanding - - - -
* In Millions of PKR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GLAX Comments

Write your thoughts about GlaxoSmithKline Pakistan Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Muhammad Javed
Muhammad Javed Feb 05, 2024 5:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hold or sell please ?
Shahid Iqbal
Shahid Iqbal Mar 22, 2021 7:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now its time to move from 156 to 180 6.5rs on one share hold rakho upper jae ga
Waqas Ali
Waqas Ali Mar 22, 2021 7:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy at current stage?
Zahid Ameen
Zahid Ameen Mar 22, 2021 7:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
160.31 Rs ki Buying hy, kab tak Barhy Ga
Zahid Ameen
Zahid Ameen Mar 22, 2021 7:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
160.31 Rs ki Buying hy, kab tak Barhy Ga
Zenith Cerebrum
Zenith Cerebrum May 21, 2020 4:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pharma sector will rise, GSK is a frontrunner in the race to develope the COVID Vaccine.
Muhammad Bilal
Muhammad Bilal Feb 13, 2020 5:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
glaxo sell target price
Anwar Hussain
Anwar Hussain Nov 17, 2019 12:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No coments here before many months, it shows there is no trading.
Riaz Ladha
Riaz Ladha Aug 14, 2017 11:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In current market situation, PKR 185/- is price where one can start accumulation.
Abrar Khan
Abrar Khan Apr 22, 2017 6:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
From this point it must go up, as all indicators favouring an upward trend .
ibrahim Ibrahim
ibrahim Ibrahim Apr 22, 2017 6:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
can you plz help me how can i make account and then buy ??? i am new what are the requirement and can 1 start from 100 us dollar
SM Javed Iqbal
SM Javed Iqbal Apr 22, 2017 6:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Which are the indicators favouring upward trend
Abdul Karim
Abdul Karim Feb 06, 2017 3:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think buy buy and more buy. 240.00 is ideal for buy according to last week. (It's my opinion and my strategy, be careful on your own risk )
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email